The following clinical trials are recruiting pediatric patients with various types of epilepsy:
- A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome
- Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms
- A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex.
- A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome
- Long-term, Prospective Study Evaluating Clinical and Molecular Biomarkers of Epileptogenesis in a Genetic Model of Epilepsy – Tuberous Sclerosis Complex (EPISTOP)
- Trial to Assess Vagus Nerve Stimulation Therapy in Children With Lennox-Gastaut Syndrome
- An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes
- Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder
- Ketogenic Diet Program for Epilepsy
- The Human Epilepsy Project (HEP)
- Genetics of Severe Early Onset Epilepsies
- Epilepsy and Mood Regulation Disorder in Children (EPILETRE)
- Surgery as a Treatment for Medically Intractable Epilepsy
- Supporting Treatment Adherence Regimens in Pediatric Epilepsy: The STAR Trial
- Ketogenic Diet in Infants With Epilepsy (KIWE) (KIWE)